Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction of antigen specific cellular immunity by vaccination with peptides from MN/CA IX in renal cell carcinoma.

Oncology reports - 1 Jan 2000

Shimizu Kazuhiro, Uemura Hirotsugu, Yoshikawa Motoyoshi, Yoshida Katsunori, Hirao Yoshihiko, Iwashima Kumiko, Saga Shinsuke, Yoshikawa Kazuhiro

Abstract excerpt

We investigated the induction of the specific immunity for renal cell carcinomas (RCC) using MN/CA IX, a tumor-associated antigen frequently expressed in RCC. We have generated 9-mer peptide derived from MN/CA IX and examined the antigenicity as a vaccine to induce specific immunity for RCC. To use mouse syngeneic system, we transfected human MN/CA9 cDNA into RenCa and BALB-3T3 cells originally from BALB/c mouse,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carbonic Anhydrases

Share to Carcinoma, Renal Cell

Share to Kidney Neoplasms

Share to NIH 3T3 Cells

Share to Spleen

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 12883698

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Induction of antigen specific cellular immunity by vaccination with peptides from MN/CA IX in renal cell carcinoma.PMID 12883698Read ↗

Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8+ T-cell ResponsesSemantic proximity Read ↗

Phase I Study of Autologous Tumor Vaccines Transduced with the GM-CSF Gene in Four Patients with Stage IV Renal Cell Cancer in Japan: Clinical and Immunological FindingsSemantic proximity Read ↗

New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.Semantic proximity Read ↗

A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes.Semantic proximity Read ↗

Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells.Semantic proximity Read ↗

Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.Semantic proximity Read ↗

Immunogene therapy of tumors with vaccine based on <i>Xenopus</i> homologous vascular endothelial growth factor as a model antigenSemantic proximity Read ↗

Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.